The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Nil Navarro-Gorro Honoraria - Astellas Pharma; Ipsen; Johnson & Johnson/Janssen; MSD Oncology Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Johnson & Johnson/Janssen; MSD Oncology   Jaume Capdevila Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi Research Funding - Advanced Accelerator Applications (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Gilead Sciences (Inst); Ipsen (Inst); Ipsen (Inst); ITM Solucin (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst) Travel, Accommodations, Expenses - Eisai; Gilead Sciences; Ipsen; Novartis; Novartis; Novartis; Pfizer   Valentina Gambardella Consulting or Advisory Role - Boehringer Ingelheim Research Funding - Amcure (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Natera (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Sierra Oncology (Inst); Takeda (Inst) Travel, Accommodations, Expenses - Boehringer Ingelheim   Yasutoshi Kuboki Honoraria - Amgen; Kyowa Kirin; Taiho Pharmaceutical; Takeda Consulting or Advisory Role - Abbvie; Amgen; Incyte Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BioNTech SE (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb Japan (Inst); Bristol-Myers Squibb Japan (Inst); Carna Biosciences (Inst); Chugai Pharma (Inst); Daiichi Sankyo/UCB Japan (Inst); Genmab (Inst); Incyte (Inst); Kyowa Kirin (Inst); Lilly (Inst); Merck Serono (Inst); Mitsubishi Tanabe Pharma (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)   Olatunji Alese Consulting or Advisory Role - AADi; AstraZeneca; Bristol-Myers Squibb; Ipsen; Pfizer; Seagen; Taiho Pharmaceutical Other Relationship - Arcus Biosciences (Inst); ASCO; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corcept Therapeutics Inc. (Inst); Cue Biopharma (Inst); GlaxoSmithKline (Inst); Hutchison MediPharma (Inst); ImmunoGen (Inst); Inhibitex Inc. (Inst); Ipsen (Inst); Merck (Inst); PCI Biotech (Inst); SynCore Biotechnology Co. Ltd. (Inst); Syros Pharmaceuticals Inc. (Inst); Taiho Oncology (Inst); Transcenta (Inst); Xencor Inc. (Inst)   Daniel Morgensztern Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb/Medarex; Johnson & Johnson/Janssen; Lilly Medical; Mirati Therapeutics; Natera; Tubulis GmbH Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genprex (Inst); Hybercell (Inst); ImmunityBio (Inst); Lilly (Inst); Merck (Inst); NeoImmuneTech (Inst); Nextcure (Inst); Pfizer (Inst); Roche (Inst); Surface Oncology (Inst); Tubulis GmbH (Inst) Patents, Royalties, Other Intellectual Property - Genprex   Cyrus Sayehli Consulting or Advisory Role - Boehringer Ingelheim (Inst) Travel, Accommodations, Expenses - Catalym   Miguel Sanmamed Honoraria - Bristol-Myers Squibb; MSD Consulting or Advisory Role - Catalym; MSD; Numab Research Funding - Roche   Matus Studeny Employment - Boehringer Ingelheim   Mohamed Bouzaggou Employment - Boehringer Ingelheim France Travel, Accommodations, Expenses - Boehringer Ingelheim France   Zhiheng Chen Employment - Boehringer Ingelheim   Valeria Lifke Employment - Boehringer Ingelheim   Juergen Wolf Honoraria - Abbvie; Amgen; Amgen Astellas BioPharma; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; DISCO Pharmaceuticals; Ellipses Pharma; Genmab; Janssen; Kingyee Beiging Co. LTD.; Lilly; Merck; Mirati Therapeutics; MSD; Novartis; Nuvalent, Inc.; Nuvation Bio; Pfizer; Regeneron; Revolution Medicines; Roche; Seagen; Takeda; Turning Point Therapeutics; Zuelling Pharma Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo/Lilly; Merck; Mirati Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Roche; Seagen; Takeda Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Janssen; Novartis; Pfizer Travel, Accommodations, Expenses - Amgen; AstraZeneca; Intellisphere; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Sanofi   Martin Wermke Honoraria - Amgen; AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; GWT; Janssen; Lilly; Merck Serono; MJH/PER; Novartis; Pfizer; Regeneron; SYNLAB; Takeda Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Genentech; ImCheck therapeutics; immatics; Iovance Biotherapeutics; ISA Pharmaceuticals; Lilly; Novartis; PharmaMar; Regeneron; Roche; T-Knife; Tacalyx; Zymeworks Research Funding - Boehringer Ingelheim (Inst); Iovance Biotherapeutics (Inst); Roche (Inst) Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; GEMoaB; immatics; Iovance Biotherapeutics; Janssen Oncology; Merck Serono; Pfizer; Sanofi/Aventis